Practical Use of Continuous Glucose Monitoring to Adjust Glucose-Lowering Therapy in Hemodialysis Patients: A Case Series.

IF 1.2

Hemodialysis international. International Symposium on Home Hemodialysis Pub Date : 2025-09-21 DOI:10.1111/hdi.70024

Christine L Meyer-Olesen, Merete B Christensen, Dea H Kofod, Mads Hornum, Kirsten Nørgaard, Tobias Bomholt

{"title":"Practical Use of Continuous Glucose Monitoring to Adjust Glucose-Lowering Therapy in Hemodialysis Patients: A Case Series.","authors":"Christine L Meyer-Olesen, Merete B Christensen, Dea H Kofod, Mads Hornum, Kirsten Nørgaard, Tobias Bomholt","doi":"10.1111/hdi.70024","DOIUrl":null,"url":null,"abstract":"Introduction: Diabetes management in hemodialysis patients is complicated by limited treatment options and challenges in glycemic monitoring. Continuous glucose monitoring (CGM) provides detailed glucose profiles, enabling tailored glucose-lowering therapy.Methods: This case series presents three insulin-treated hemodialysis patients with type 1 or type 2 diabetes.Findings: Each case reveals significant glycemic abnormalities, including excessive hyperglycemia with nocturnal glucose drops, unrecognized hypoglycemia, and extreme glucose variability. We propose specific personalized insulin adjustments based on CGM readings to optimize treatment across these different clinical scenarios.Conclusions: The case series highlights the potential to rethink glucose monitoring in hemodialysis patients with diabetes and underlines the need for future studies evaluating CGM use in this population.","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis international. International Symposium on Home Hemodialysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/hdi.70024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Diabetes management in hemodialysis patients is complicated by limited treatment options and challenges in glycemic monitoring. Continuous glucose monitoring (CGM) provides detailed glucose profiles, enabling tailored glucose-lowering therapy.

Methods: This case series presents three insulin-treated hemodialysis patients with type 1 or type 2 diabetes.

Findings: Each case reveals significant glycemic abnormalities, including excessive hyperglycemia with nocturnal glucose drops, unrecognized hypoglycemia, and extreme glucose variability. We propose specific personalized insulin adjustments based on CGM readings to optimize treatment across these different clinical scenarios.

Conclusions: The case series highlights the potential to rethink glucose monitoring in hemodialysis patients with diabetes and underlines the need for future studies evaluating CGM use in this population.

查看原文本刊更多论文

连续血糖监测在血液透析患者降糖治疗中的实际应用：一个病例系列。

血液透析患者的糖尿病管理由于治疗选择有限和血糖监测方面的挑战而变得复杂。连续血糖监测（CGM）提供详细的血糖谱，使量身定制的降糖治疗成为可能。方法：本病例系列报道3例胰岛素治疗的1型或2型糖尿病血液透析患者。结果：每个病例都表现出明显的血糖异常，包括夜间血糖下降的过度高血糖，未被识别的低血糖和极端的血糖变异性。我们建议根据CGM读数进行特定的个性化胰岛素调整，以优化这些不同临床情况下的治疗。结论：该病例系列强调了重新思考糖尿病血液透析患者血糖监测的潜力，并强调了未来研究评估CGM在该人群中的应用的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hemodialysis international. International Symposium on Home Hemodialysis

自引率

0.00%

发文量